169 related articles for article (PubMed ID: 38146439)
21. Roles of cytokines and T cells in the pathogenesis of myasthenia gravis.
Uzawa A; Kuwabara S; Suzuki S; Imai T; Murai H; Ozawa Y; Yasuda M; Nagane Y; Utsugisawa K
Clin Exp Immunol; 2021 Mar; 203(3):366-374. PubMed ID: 33184844
[TBL] [Abstract][Full Text] [Related]
22. Clinical Experience with Eculizumab in Treatment-Refractory Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis.
Katyal N; Narula N; Govindarajan R
J Neuromuscul Dis; 2021; 8(2):287-294. PubMed ID: 33325394
[TBL] [Abstract][Full Text] [Related]
23. Augmentation of Circulating Follicular Helper T Cells and Their Impact on Autoreactive B Cells in Myasthenia Gravis.
Zhang CJ; Gong Y; Zhu W; Qi Y; Yang CS; Fu Y; Chang G; Li Y; Shi S; Wood K; Ladha S; Shi FD; Liu Q; Yan Y
J Immunol; 2016 Oct; 197(7):2610-7. PubMed ID: 27543617
[TBL] [Abstract][Full Text] [Related]
24. Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK.
Yilmaz V; Oflazer P; Aysal F; Durmus H; Poulas K; Yentur SP; Gulsen-Parman Y; Tzartos S; Marx A; Tuzun E; Deymeer F; Saruhan-Direskeneli G
PLoS One; 2015; 10(4):e0123546. PubMed ID: 25893403
[TBL] [Abstract][Full Text] [Related]
25. CXCR5-negative natural killer cells ameliorate experimental autoimmune myasthenia gravis by suppressing follicular helper T cells.
Yang CL; Zhang P; Liu RT; Zhang N; Zhang M; Li H; Du T; Li XL; Dou YC; Duan RS
J Neuroinflammation; 2019 Dec; 16(1):282. PubMed ID: 31884963
[TBL] [Abstract][Full Text] [Related]
26. Prophylactic administration of fingolimod (FTY720) ameliorated experimental autoimmune myasthenia gravis by reducing the number of dendritic cells, follicular T helper cells and antibody-secreting cells.
Liu Y; Yang CL; Yang B; Du T; Li XL; Zhang P; Ge MR; Lian Y; Li H; Liu YD; Duan RS
Int Immunopharmacol; 2021 Jul; 96():107511. PubMed ID: 33915521
[TBL] [Abstract][Full Text] [Related]
27. Central Role of T Follicular Helper Cells in Myasthenia Gravis.
Wu N; Tüzün E; Cheng Y; Yan L; Wu Y; Rao J; Huang H; Li S; Shi L; Wu X
Noro Psikiyatr Ars; 2021 Mar; 58(1):68-72. PubMed ID: 33795956
[TBL] [Abstract][Full Text] [Related]
28. A regulatory effect of IL-21 on T follicular helper-like cell and B cell in rheumatoid arthritis.
Liu R; Wu Q; Su D; Che N; Chen H; Geng L; Chen J; Chen W; Li X; Sun L
Arthritis Res Ther; 2012 Nov; 14(6):R255. PubMed ID: 23176102
[TBL] [Abstract][Full Text] [Related]
29. Gender differences in clinical outcomes in myasthenia gravis: A prospective cohort study.
Thomsen JLS; Vinge L; Harbo T; Andersen H
Muscle Nerve; 2021 Nov; 64(5):538-544. PubMed ID: 34036597
[TBL] [Abstract][Full Text] [Related]
30. Disequilibrium of T helper type 1, 2 and 17 cells and regulatory T cells during the development of experimental autoimmune myasthenia gravis.
Mu L; Sun B; Kong Q; Wang J; Wang G; Zhang S; Wang D; Liu Y; Liu Y; An H; Li H
Immunology; 2009 Sep; 128(1 Suppl):e826-36. PubMed ID: 19740344
[TBL] [Abstract][Full Text] [Related]
31. Thymoma patients with or without myasthenia gravis have increased Th17 cells, IL-17 production and ICOS expression.
Cebi M; Cakar A; Erdogdu E; Durmus-Tekce H; Yegen G; Ozkan B; Parman Y; Saruhan-Direskeneli G
J Neuroimmunol; 2023 Aug; 381():578129. PubMed ID: 37329662
[TBL] [Abstract][Full Text] [Related]
32. IL-37 Represses the Autoimmunity in Myasthenia Gravis via Directly Targeting Follicular Th and B Cells.
Liu Z; Zhu L; Lu Z; Chen H; Fan L; Xue Q; Shi J; Li M; Li H; Gong J; Shi J; Wang T; Jiang ML; Cao R; Meng H; Wang C; Xu Y; Zhang CJ
J Immunol; 2020 Apr; 204(7):1736-1745. PubMed ID: 32111731
[TBL] [Abstract][Full Text] [Related]
33. Effect of tacrolimus on soluble costimulatory molecules in patients with refractory myasthenia gravis.
Wu H; Chen L; Zhou X; Wu Y; Yan Y; Zhu Y; Zhao C; Xue Q
J Neuroimmunol; 2022 Nov; 372():577955. PubMed ID: 36054935
[TBL] [Abstract][Full Text] [Related]
34. B Cell Depletion Therapy Normalizes Circulating Follicular Th Cells in Primary Sjögren Syndrome.
Verstappen GM; Kroese FG; Meiners PM; Corneth OB; Huitema MG; Haacke EA; van der Vegt B; Arends S; Vissink A; Bootsma H; Abdulahad WH
J Rheumatol; 2017 Jan; 44(1):49-58. PubMed ID: 28042126
[TBL] [Abstract][Full Text] [Related]
35. Eculizumab improves fatigue in refractory generalized myasthenia gravis.
Andersen H; Mantegazza R; Wang JJ; O'Brien F; Patra K; Howard JF;
Qual Life Res; 2019 Aug; 28(8):2247-2254. PubMed ID: 30905021
[TBL] [Abstract][Full Text] [Related]
36. Leflunomide ameliorates experimental autoimmune myasthenia gravis by regulating humoral and cellular immune responses.
Huang H; Ran H; Liu X; Yu L; Qiu L; Lin Z; Ou C; Lu Y; Yang W; Liu W
Int Immunopharmacol; 2021 Apr; 93():107434. PubMed ID: 33556668
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-29 regulates T follicular helper cells by repressing BCL6 in rheumatoid arthritis patients.
Xu T; Yan T; Li P
Clin Rheumatol; 2020 Dec; 39(12):3797-3804. PubMed ID: 32468318
[TBL] [Abstract][Full Text] [Related]
38. Elevated circulating Th17 and follicular helper CD4(+) T cells in patients with rheumatoid arthritis.
Zhang Y; Li Y; Lv TT; Yin ZJ; Wang XB
APMIS; 2015 Aug; 123(8):659-66. PubMed ID: 25912557
[TBL] [Abstract][Full Text] [Related]
39. Increased frequency of thymic T follicular helper cells in myasthenia gravis patients with thymoma.
Song Y; Zhou L; Miao F; Chen G; Zhu Y; Gao X; Wang Y; Pang L; Zhao C; Sun X; Chen Z
J Thorac Dis; 2016 Mar; 8(3):314-22. PubMed ID: 27076925
[TBL] [Abstract][Full Text] [Related]
40. Imbalance of circulating CD4(+)CXCR5(+)FOXP3(+) Tfr-like cells and CD4(+)CXCR5(+)FOXP3(-) Tfh-like cells in myasthenia gravis.
Wen Y; Yang B; Lu J; Zhang J; Yang H; Li J
Neurosci Lett; 2016 Sep; 630():176-182. PubMed ID: 27473945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
